Policy & Systems

Featured

Crowdfunding for Global Health: a novel solution or temporary fix? 

By Elizabeth Sherwin and Katia Cnop Elizabeth Sherwin was the Watsi Fellow working with Maya Health Alliance in Guatemala for 2016-2017. Katia Cnop is a Read More

Do Mothers Have a Say?

A recent breakthrough in genetic engineering suggests new options in treating genetic diseases while raises ethical concerns. By Yvaine Ye Her phone rang. It was Read More

Global health work: Reflective practice and the joy of letter writing

By Saqib Noor I remember lying in a flimsy hammock, hung between two tall raphia palm trees, swinging gently under a glistening African night sky. I Read More

Latest

WHO Must Ensure Taiwan Not Excluded From Global Health Discussions

Foreign Affairs: Letter: Room for Everyone Brian Su, deputy director general at Taipei Economic and Cultural Office “…For years, Taiwan has been excluded from the WHO. Continuing this practice will not serve Tedros’ purposes [to increase health care coverage and ‘leave no one behind’] well. Taiwan has one of the world’s best universal health care…More


Oxfam America Blog Post Examines U.S. Foreign Aid, National Debt

Oxfam America’s “Politics of Poverty”: President Trump thinks cutting aid will fix U.S. debt. But his numbers don’t add up. Heather Schommer, senior writer for aid effectiveness at Oxfam America, writes about statements made by President Trump on U.S. foreign aid and the national debt


World Politics Review Examines New PEPFAR Strategy, Trump Administration’s Commitment To…

World Politics Review: The Mismatch Between the Rhetoric and Reality of Tillerson’s New PEPFAR Strategy “…[W]hile PEPFAR may be off the chopping block, the Trump administration’s new strategy seems to perpetuate trends that have activists worried about the long-term fight against HIV/AIDS. … First, for all its talk of U.S. commitment to PEPFAR, the administration…More


Devex Highlights Key Health Priorities Discussed During Western Pacific WHO Regional Committee…

Devex: Health priorities for the Pacific: Insights from WHO’s Regional Committee for the Western Pacific “Food marketing and safety, immunization, mother-to-child disease transmission, and strengthened health workforce and services are among the health priorities of member states at the 68th session of the World Health Organization Regional Committee for the Western Pacific, held in Brisbane…More


WHO’s Announcement Of New Leadership Cabinet, New Priorities Brings ‘Valuable Momentum To…

The Lancet: WHO launches new leadership, new priorities Editorial Board “WHO’s Director-General, Dr. Tedros, last week launched his new cabinet to widespread acclaim. … The announcement also translated Tedros’s verbal promises into structural commitments. New priorities include Universal Health Coverage, climate change, and access to medicines.


2017 UNC-IntraHealth Fellows Explore HIV Stigma, Sexual Harassment in the Health Workforce, and…

From left: Rebecca Kohler (senior vice president of corporate strategy and development at IntraHealth), Kati Jackson, Pape Gaye (president and CEO at IntraHealth), Yutaka Endo, Alex Dest, Peggy Bentley (associate dean for global health at UNC), and Saja Al-Falahi. Photo by Carol Bales for IntraHealth International. October 13, 2017 Graduates of the eighth annual UNC-IntraHealth Summer Fellows Program spent ten weeks working side-by-side with global health professionals at IntraHealth International this summer, taking on projects that ranged from HIV-related stigma to sexual harassment and discrimination in the health workforce. Since 2010, IntraHealth and the University of North Carolina at Chapel Hill’s (UNC) Gillings School of Global Public Health have teamed up to offer this fellowship program, through which graduate and doctoral students get hands-on experience in the field of global health at an international nongovernmental organization. Thirty-four fellows have now completed the program.


Little Global Progress On Cataracts, Leading Cause Of Blindness, Report Shows; Innovative…

Devex: Progress on ending leading cause of blindness at near standstill, report says “The past 30 years have seen little to no reduction in the leading cause of blindness among people aged 50 and over in developing regions, data published Thursday in The Lancet reveals. The research, conducted by the Vision Loss Expert Group, shows…More


Advocates Seek 3rd U.N. High-Level Meeting On NCDs To Create New Financing Mechanisms; WHO…

Devex: Advocates seek noncommunicable disease funding mechanisms “Advocates are pushing for the third U.N. high-level meeting on noncommunicable diseases next September to create new financing mechanisms, experts have told Devex. At a media briefing in Mexico City last week, experts from the NCD Alliance expressed concern with the lack of progress on tackling NCDs, which…More


CGD Launches New Book On Designing Health Benefits Package For UHC

Center for Global Development’s “Global Health Policy Blog”: Defining Benefits for Universal Health Care — How Governments Can Get the Most Bang for Their Health Care Buck Amanda Glassman, chief operating officer and senior fellow at CGD, and Rebecca Forman, program coordinator for the Global Health Policy team at CGD, discuss the launch of and…More


CDC Working With National Governments To Eliminate Measles, Rubella Worldwide

CDC’s “Our Global Voices”: Looking Ahead to a Measles and Rubella Free World Robert Linkins, chair of the Measles & Rubella Initiative, and chief of the Accelerated Disease Control and Surveillance Branch at the CDC Global Immunization Division, discusses efforts to eliminate measles, rubella, and the associated congenital rubella syndrome (CRS), which can cause birth…More


Beware of pharmaceutical companies bearing cheap drugs

Pharmaceutical companies are for-profit enterprises that make their money by selling medicinal drugs. This might seem stupefyingly obvious, but it can get (briefly) obscured when these companies distribute shiny pamphlets suggesting that the promotion of human well-being is their ultimate mission or when they act in seemingly philanthropic ways. Scratch the surface, or just wait until the smoke clears, and the profit motive comes back into view. This is partly why bioethics workers find pharmaceutical companies fascinating and appalling: sometimes they offer a glimpse of what it would be like if powerful multinationals really threw their weight behind public health goals, but only a glimpse, because they inevitably veer off to make money and please their stockholders, sometimes in ways at odds with the ethics of research and health care. They are a kind of ethical rogue element.


Picture It: Active Listening in Progress


Picture It: A Quiet, Gentle Voice


Picture It: Now, Customer Service Centers


Older Posts »